{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T02:05:55Z","timestamp":1780106755677,"version":"3.54.0"},"reference-count":109,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T00:00:00Z","timestamp":1753142400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T00:00:00Z","timestamp":1753142400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Mol Neurobiol"],"DOI":"10.1007\/s10571-025-01596-4","type":"journal-article","created":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T06:23:53Z","timestamp":1753165433000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Kynurenine Pathway Modulation by Exercise in Multiple Sclerosis: Implications for Neuroprotection and Inflammation"],"prefix":"10.1007","volume":"45","author":[{"given":"Rastegar","family":"Hoseini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elnaz","family":"Ghafari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,22]]},"reference":[{"key":"1596_CR1","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.bbi.2015.07.016","volume":"51","author":"S Aeinehband","year":"2016","unstructured":"Aeinehband S, Brenner P, St\u00e5hl S, Bhat M, Fidock MD, Khademi M, Olsson T, Engberg G, Jokinen J, Erhardt S (2016) Cerebrospinal fluid kynurenines in multiple sclerosis; relation to disease course and neurocognitive symptoms. Brain Behav Immun 51:47\u201355","journal-title":"Brain Behav Immun"},{"issue":"1","key":"1596_CR2","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.cell.2014.07.051","volume":"159","author":"LZ Agudelo","year":"2014","unstructured":"Agudelo LZ, Femen\u00eda T, Orhan F, Porsmyr-Palmertz M, Goiny M, Martinez-Redondo V, Correia JC, Izadi M, Bhat M, Schuppe-Koistinen I (2014) Skeletal muscle PGC-1\u03b11 modulates kynurenine metabolism and mediates resilience to stress-induced depression. Cell 159(1):33\u201345","journal-title":"Cell"},{"issue":"2","key":"1596_CR3","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1080\/15548627.2023.2259281","volume":"20","author":"HM Al-Kuraishy","year":"2024","unstructured":"Al-Kuraishy HM, Jabir MS, Al-Gareeb AI, Saad HM, Batiha GE-S, Klionsky DJ (2024) The beneficial role of autophagy in multiple sclerosis: yes or no? Autophagy 20(2):259\u2013274","journal-title":"Autophagy"},{"key":"1596_CR4","doi-asserted-by":"publisher","DOI":"10.1152\/ajpcell.00448.2018","author":"DJ Allison","year":"2019","unstructured":"Allison DJ, Nederveen JP, Snijders T, Bell KE, Kumbhare D, Phillips SM, Parise G, Heisz JJ (2019) Exercise training impacts skeletal muscle gene expression related to the kynurenine pathway. Am J Physiol Cell Physiol. https:\/\/doi.org\/10.1152\/ajpcell.00448.2018","journal-title":"Am J Physiol Cell Physiol"},{"issue":"9","key":"1596_CR5","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0138376","volume":"10","author":"F Areces","year":"2015","unstructured":"Areces F, Gonz\u00e1lez-Mill\u00e1n C, Salinero JJ, Abian-Vicen J, Lara B, Gallo-Salazar C, Ruiz-Vicente D, Del Coso J (2015) Changes in serum free amino acids and muscle fatigue experienced during a half-ironman triathlon. PLoS ONE 10(9):e0138376","journal-title":"PLoS ONE"},{"issue":"13","key":"1596_CR6","doi-asserted-by":"publisher","first-page":"7201","DOI":"10.3390\/ijerph18137201","volume":"18","author":"MM Atakan","year":"2021","unstructured":"Atakan MM, Li Y, Ko\u015far \u015eN, Turnag\u00f6l HH, Yan X (2021) Evidence-based effects of high-intensity interval training on exercise capacity and health: a review with historical perspective. Int J Environ Res Public Health 18(13):7201","journal-title":"Int J Environ Res Public Health"},{"key":"1596_CR7","doi-asserted-by":"publisher","first-page":"1421346","DOI":"10.3389\/fimmu.2024.1421346","volume":"15","author":"F Bahman","year":"2024","unstructured":"Bahman F, Choudhry K, Al-Rashed F, Al-Mulla F, Sindhu S, Ahmad R (2024) Aryl hydrocarbon receptor: current perspectives on key signaling partners and immunoregulatory role in inflammatory diseases. Front Immunol 15:1421346","journal-title":"Front Immunol"},{"issue":"8","key":"1596_CR8","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1016\/j.scispo.2021.12.014","volume":"37","author":"E Bahmani","year":"2022","unstructured":"Bahmani E, Hoseini R, Amiri E (2022a) The effect of home-based aerobic training and vitamin D supplementation on fatigue and quality of life in patients with multiple sclerosis during COVID-19 outbreak. Sci Sports 37(8):710\u2013719","journal-title":"Sci Sports"},{"key":"1596_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2022.103693","volume":"60","author":"E Bahmani","year":"2022","unstructured":"Bahmani E, Hoseini R, Amiri E (2022b) Home-based aerobic training and vitamin D improve neurotrophins and inflammatory biomarkers in MS patients. Mult Scler Relat Disord 60:103693","journal-title":"Mult Scler Relat Disord"},{"key":"1596_CR10","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.jneuroim.2017.12.001","volume":"314","author":"J Bansi","year":"2018","unstructured":"Bansi J, Koliamitra C, Bloch W, Joisten N, Schenk A, Watson M, Kool J, Langdon D, Dalgas U, Kesselring J (2018) Persons with secondary progressive and relapsing remitting multiple sclerosis reveal different responses of tryptophan metabolism to acute endurance exercise and training. J Neuroimmunol 314:101\u2013105","journal-title":"J Neuroimmunol"},{"key":"1596_CR11","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2016.00194","volume":"7","author":"A Barry","year":"2016","unstructured":"Barry A, Cronin O, Ryan AM, Sweeney B, Yap SM, O\u2019Toole O, Allen AP, Clarke G, O\u2019Halloran KD, Downer EJ (2016) Impact of exercise on innate immunity in multiple sclerosis progression and symptomatology. Front Physiol 7:194","journal-title":"Front Physiol"},{"key":"1596_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2024.105479","volume":"84","author":"M Barzegar","year":"2024","unstructured":"Barzegar M, Vaheb S, Mirmosayyeb O, Ashtari F, Afshari-Safavi A, Adibi I, Shaygannejad A, Mazaheri S, Rahimi M (2024) Prevalence and incidence of multiple sclerosis in Isfahan, Iran between 1996 and 2021: a population-based study. Mult Scler Relat Disord 84:105479","journal-title":"Mult Scler Relat Disord"},{"key":"1596_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2021.766511","volume":"12","author":"C Bello","year":"2021","unstructured":"Bello C, Heinisch PP, Mihalj M, Carrel T, Luedi MM (2021) Indoleamine-2, 3-dioxygenase as a perioperative marker of the immune system. Front Physiol 12:766511","journal-title":"Front Physiol"},{"issue":"6","key":"1596_CR14","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.3390\/cells9061564","volume":"9","author":"T Biernacki","year":"2020","unstructured":"Biernacki T, Sandi D, Bencsik K, V\u00e9csei L (2020) Kynurenines in the pathogenesis of multiple sclerosis: therapeutic perspectives. Cells 9(6):1564","journal-title":"Cells"},{"key":"1596_CR15","doi-asserted-by":"publisher","DOI":"10.4137\/IJTR.S2097","volume":"2","author":"Y Chen","year":"2009","unstructured":"Chen Y, Guillemin GJ (2009) Kynurenine pathway metabolites in humans: disease and healthy states. Int J Tryptophan Res 2:IJTR. S2097","journal-title":"Int J Tryptophan Res"},{"issue":"12","key":"1596_CR16","doi-asserted-by":"publisher","first-page":"4339","DOI":"10.1002\/jcp.30876","volume":"237","author":"Y Chen","year":"2022","unstructured":"Chen Y, Zhang J, Yang Y, Xiang K, Li H, Sun D, Chen L (2022) Kynurenine-3-monooxygenase (KMO): from its biological functions to therapeutic effect in diseases progression. J Cell Physiol 237(12):4339\u20134355","journal-title":"J Cell Physiol"},{"issue":"1","key":"1596_CR17","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1093\/toxsci\/kfq024","volume":"115","author":"BC DiNatale","year":"2010","unstructured":"DiNatale BC, Murray IA, Schroeder JC, Flaveny CA, Lahoti TS, Laurenzana EM, Omiecinski CJ, Perdew GH (2010) Kynurenic acid is a potent endogenous aryl hydrocarbon receptor ligand that synergistically induces interleukin-6 in the presence of inflammatory signaling. Toxicol Sci 115(1):89\u201397","journal-title":"Toxicol Sci"},{"issue":"9","key":"1596_CR18","doi-asserted-by":"publisher","first-page":"2489","DOI":"10.3390\/biomedicines11092489","volume":"11","author":"L Eva","year":"2023","unstructured":"Eva L, Ple\u0219 H, Covache-Busuioc R-A, Glavan LA, Bratu B-G, Bordeianu A, Dumitrascu D-I, Corlatescu AD, Ciurea AV (2023) A comprehensive review on neuroimmunology: insights from multiple sclerosis to future therapeutic developments. Biomedicines 11(9):2489","journal-title":"Biomedicines"},{"issue":"2","key":"1596_CR19","doi-asserted-by":"publisher","first-page":"426","DOI":"10.3390\/ijms20020426","volume":"20","author":"B Fakan","year":"2019","unstructured":"Fakan B, Szalardy L, Vecsei L (2019) Exploiting the therapeutic potential of endogenous immunomodulatory systems in multiple sclerosis\u2014special focus on the peroxisome proliferator-activated receptors (PPARs) and the kynurenines. Int J Mol Sci 20(2):426","journal-title":"Int J Mol Sci"},{"key":"1596_CR20","doi-asserted-by":"publisher","first-page":"1471642","DOI":"10.3389\/fmed.2024.1471642","volume":"11","author":"R Fan","year":"2024","unstructured":"Fan R, Kong J, Zhang J, Zhu L (2024) Exercise as a therapeutic approach to alleviate diabetic kidney disease: mechanisms, clinical evidence and potential exercise prescriptions. Front Med 11:1471642","journal-title":"Front Med"},{"key":"1596_CR21","doi-asserted-by":"publisher","first-page":"1013784","DOI":"10.3389\/fimmu.2022.1013784","volume":"13","author":"M Fathi","year":"2022","unstructured":"Fathi M, Vakili K, Yaghoobpoor S, Tavasol A, Jazi K, Mohamadkhani A, Klegeris A, McElhinney A, Mafi Z, Hajiesmaeili M (2022) Dynamic changes in kynurenine pathway metabolites in multiple sclerosis: a systematic review. Front Immunol 13:1013784","journal-title":"Front Immunol"},{"issue":"16","key":"1596_CR22","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25169082","volume":"25","author":"L de F\u00e1tima Alves","year":"2024","unstructured":"de F\u00e1tima Alves L, Moore JB, Kell DB (2024) The biology and biochemistry of kynurenic acid, a potential nutraceutical with multiple biological effects. Int J Mol Sci 25(16):9082","journal-title":"Int J Mol Sci"},{"issue":"1","key":"1596_CR23","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1111\/j.1365-2567.2008.02881.x","volume":"126","author":"ME Fransson","year":"2009","unstructured":"Fransson ME, Liljenfeldt LS, Fagius J, T\u00f6tterman TH, Loskog AS (2009) The T-cell pool is anergized in patients with multiple sclerosis in remission. Immunology 126(1):92\u2013101","journal-title":"Immunology"},{"issue":"8","key":"1596_CR24","doi-asserted-by":"publisher","first-page":"606","DOI":"10.3390\/cells14080606","volume":"14","author":"F Galota","year":"2025","unstructured":"Galota F, Marcheselli S, De Biasi S, Gibellini L, Vitetta F, Fiore A, Smolik K, De Napoli G, Cardi M, Cossarizza A (2025) Impact of high-efficacy therapies for multiple sclerosis on B cells. Cells 14(8):606","journal-title":"Cells"},{"issue":"1\u20132","key":"1596_CR25","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.jneuroim.2009.10.015","volume":"221","author":"R Gandhi","year":"2010","unstructured":"Gandhi R, Laroni A, Weiner HL (2010) Role of the innate immune system in the pathogenesis of multiple sclerosis. J Neuroimmunol 221(1\u20132):7\u201314","journal-title":"J Neuroimmunol"},{"issue":"13","key":"1596_CR26","doi-asserted-by":"publisher","first-page":"6933","DOI":"10.3390\/ijms25136933","volume":"25","author":"AY Grishanova","year":"2024","unstructured":"Grishanova AY, Perepechaeva ML (2024) Kynurenic acid\/AhR signaling at the junction of inflammation and cardiovascular diseases. Int J Mol Sci 25(13):6933","journal-title":"Int J Mol Sci"},{"issue":"2","key":"1596_CR27","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1111\/j.1600-0404.2005.00442.x","volume":"112","author":"Z Hartai","year":"2005","unstructured":"Hartai Z, Klivenyi P, Janaky T, Penke B, Dux L, Vecsei L (2005a) Kynurenine metabolism in multiple sclerosis. Acta Neurol Scand 112(2):93\u201396","journal-title":"Acta Neurol Scand"},{"issue":"2","key":"1596_CR28","doi-asserted-by":"publisher","first-page":"84","DOI":"10.3390\/cells8020084","volume":"8","author":"S Herman","year":"2019","unstructured":"Herman S, \u00c5kerfeldt T, Spjuth O, Burman J, Kultima K (2019) Biochemical differences in cerebrospinal fluid between secondary progressive and relapsing\u2013remitting multiple sclerosis. Cells 8(2):84","journal-title":"Cells"},{"issue":"11","key":"1596_CR29","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.1113\/JP284142","volume":"601","author":"JM Hinkley","year":"2023","unstructured":"Hinkley JM, Yu GX, Standley RA, Distefano G, Tolstikov V, Narain NR, Greenwood BP, Karmacharya S, Kiebish MA, Carnero EA (2023) Exercise and ageing impact the kynurenine\/tryptophan pathway and acylcarnitine metabolite pools in skeletal muscle of older adults. J Physiol 601(11):2165\u20132188","journal-title":"J Physiol"},{"key":"1596_CR30","doi-asserted-by":"publisher","first-page":"388","DOI":"10.3389\/fimmu.2020.00388","volume":"11","author":"Y-S Huang","year":"2020","unstructured":"Huang Y-S, Ogbechi J, Clanchy FI, Williams RO, Stone TW (2020) IDO and kynurenine metabolites in peripheral and CNS disorders. Front Immunol 11:388","journal-title":"Front Immunol"},{"issue":"3","key":"1596_CR31","doi-asserted-by":"publisher","first-page":"858","DOI":"10.14336\/AD.2022.0916","volume":"14","author":"Y Huang","year":"2023","unstructured":"Huang Y, Zhao M, Chen X, Zhang R, Le A, Hong M, Zhang Y, Jia L, Zang W, Jiang C (2023) Tryptophan metabolism in central nervous system diseases: pathophysiology and potential therapeutic strategies. Aging Dis 14(3):858","journal-title":"Aging Dis"},{"issue":"1","key":"1596_CR32","doi-asserted-by":"publisher","first-page":"273","DOI":"10.3390\/molecules27010273","volume":"27","author":"TD Hughes","year":"2022","unstructured":"Hughes TD, G\u00fcner OF, Iradukunda EC, Phillips RS, Bowen JP (2022) The kynurenine pathway and kynurenine 3-monooxygenase inhibitors. Molecules 27(1):273","journal-title":"Molecules"},{"key":"1596_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2023.104898","volume":"77","author":"SMT Is\u0131k","year":"2023","unstructured":"Is\u0131k SMT, Onmaz DE, Ekmekci AH, Ozturk S, Unlu A, Abusoglu S (2023) Relationship of tryptophan metabolites with the type and severity of multiple sclerosis. Mult Scler Relat Disord 77:104898","journal-title":"Mult Scler Relat Disord"},{"issue":"1","key":"1596_CR34","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1038\/s41598-021-81306-4","volume":"11","author":"J Isung","year":"2021","unstructured":"Isung J, Granqvist M, Trepci A, Huang J, Schwieler L, Kierkegaard M, Erhardt S, Jokinen J, Piehl F (2021) Differential effects on blood and cerebrospinal fluid immune protein markers and kynurenine pathway metabolites from aerobic physical exercise in healthy subjects. Sci Rep 11(1):1669","journal-title":"Sci Rep"},{"issue":"23","key":"1596_CR35","doi-asserted-by":"publisher","first-page":"2471","DOI":"10.2174\/0929867324666170502123114","volume":"24","author":"RK Jacobs","year":"2017","unstructured":"Jacobs RK, Castellano-Gonzalez G, Guillemin JG, Lovejoy BD (2017) Major developments in the design of inhibitors along the kynurenine pathway. Curr Med Chem 24(23):2471\u20132495","journal-title":"Curr Med Chem"},{"issue":"1","key":"1596_CR36","doi-asserted-by":"publisher","first-page":"15963","DOI":"10.1038\/s41598-022-20164-0","volume":"12","author":"Y Jand","year":"2022","unstructured":"Jand Y, Ghahremani MH, Ghanbari A, Ejtemaei-Mehr S, Guillemin GJ, Ghazi-Khansari M (2022) Melatonin ameliorates disease severity in a mouse model of multiple sclerosis by modulating the kynurenine pathway. Sci Rep 12(1):15963","journal-title":"Sci Rep"},{"key":"1596_CR37","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.bbi.2021.04.020","volume":"96","author":"F Javelle","year":"2021","unstructured":"Javelle F, Bloch W, Knoop A, Guillemin GJ, Zimmer P (2021) Toward a neuroprotective shift: eight weeks of high intensity interval training reduces the neurotoxic kynurenine activity concurrently to impulsivity in emotionally impulsive humans\u2013a randomized controlled trial. Brain Behav Immun 96:7\u201317","journal-title":"Brain Behav Immun"},{"key":"1596_CR38","doi-asserted-by":"publisher","first-page":"117864692093868","DOI":"10.1177\/1178646920938688","volume":"13","author":"N Joisten","year":"2020","unstructured":"Joisten N, Walzik D, Metcalfe AJ, Bloch W, Zimmer P (2020) Physical exercise as kynurenine pathway modulator in chronic diseases: implications for immune and energy homeostasis. Int J Tryptophan Res 13:1178646920938688","journal-title":"Int J Tryptophan Res"},{"issue":"3","key":"1596_CR39","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000982","volume":"8","author":"N Joisten","year":"2021","unstructured":"Joisten N, Rademacher A, Warnke C, Proschinger S, Schenk A, Walzik D, Knoop A, Thevis M, Steffen F, Bittner S (2021) Exercise diminishes plasma neurofilament light chain and reroutes the kynurenine pathway in multiple sclerosis. Neurol Neuroimmunol Neuroinflamm 8(3):e982","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"1596_CR40","doi-asserted-by":"publisher","DOI":"10.1007\/s00421-021-04834-x","author":"S Kamandulis","year":"2022","unstructured":"Kamandulis S, Mickevicius M, Snieckus A, Streckis V, Montiel-Rojas D, Chaillou T, Westerblad H, Venckunas T (2022) Increasing the resting time between drop jumps lessens delayed-onset muscle soreness and limits the extent of prolonged low-frequency force depression in human knee extensor muscles. Eur J Appl Physiol. https:\/\/doi.org\/10.1007\/s00421-021-04834-x","journal-title":"Eur J Appl Physiol"},{"issue":"3","key":"1596_CR41","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1007\/s00438-022-01878-2","volume":"297","author":"S Kong","year":"2022","unstructured":"Kong S, Cai B, Nie Q (2022) PGC-1\u03b1 affects skeletal muscle and adipose tissue development by regulating mitochondrial biogenesis. Mol Genet Genomics 297(3):621\u2013633","journal-title":"Mol Genet Genomics"},{"issue":"18","key":"1596_CR42","doi-asserted-by":"publisher","first-page":"9879","DOI":"10.3390\/ijms22189879","volume":"22","author":"A Krupa","year":"2021","unstructured":"Krupa A, Kowalska I (2021) The kynurenine pathway\u2014new linkage between innate and adaptive immunity in autoimmune endocrinopathies. Int J Mol Sci 22(18):9879","journal-title":"Int J Mol Sci"},{"key":"1596_CR43","doi-asserted-by":"publisher","first-page":"117864692412844","DOI":"10.1177\/11786469241284423","volume":"17","author":"M Kupjetz","year":"2024","unstructured":"Kupjetz M, Patt N, Joisten N, Ueland PM, McCann A, Gonzenbach R, Bansi J, Zimmer P (2024) Baseline inflammation but not exercise modality impacts exercise-induced kynurenine pathway modulation in persons with multiple sclerosis: secondary results from a randomized controlled trial. Int J Tryptophan Res 17:11786469241284424","journal-title":"Int J Tryptophan Res"},{"issue":"33","key":"1596_CR44","doi-asserted-by":"publisher","first-page":"33ra37","DOI":"10.1126\/scitranslmed.3001006","volume":"2","author":"GD Lewis","year":"2010","unstructured":"Lewis GD, Farrell L, Wood MJ, Martinovic M, Arany Z, Rowe GC, Souza A, Cheng S, McCabe EL, Yang E (2010) Metabolic signatures of exercise in human plasma. Sci Transl Med 2(33):33ra37-33ra37","journal-title":"Sci Transl Med"},{"issue":"1","key":"1596_CR45","volume":"2022","author":"Y Liang","year":"2022","unstructured":"Liang Y, Xie S, He Y, Xu M, Qiao X, Zhu Y, Wu W (2022) Kynurenine pathway metabolites as biomarkers in Alzheimer\u2019s disease. Dis Markers 2022(1):9484217","journal-title":"Dis Markers"},{"key":"1596_CR46","doi-asserted-by":"publisher","first-page":"117864692199111","DOI":"10.1177\/1178646921991119","volume":"14","author":"A Lim","year":"2021","unstructured":"Lim A, Harijanto C, Vogrin S, Guillemin G, Duque G (2021) Does exercise influence kynurenine\/tryptophan metabolism and psychological outcomes in persons with age-related diseases? A systematic review. Int J Tryptophan Res 14:1178646921991119","journal-title":"Int J Tryptophan Res"},{"issue":"2","key":"1596_CR47","first-page":"210","volume":"33","author":"G Liu","year":"2024","unstructured":"Liu G, Li H (2024) High-intensity interval training (HIIT): impacts on cardiovascular fitness and muscle development. Revista De Psicolog\u00eda Del Deporte (Journal of Sport Psychology) 33(2):210\u2013219","journal-title":"Revista De Psicolog\u00eda Del Deporte (Journal of Sport Psychology)"},{"key":"1596_CR48","doi-asserted-by":"publisher","first-page":"1076421","DOI":"10.3389\/fgene.2023.1076421","volume":"14","author":"L Lorefice","year":"2023","unstructured":"Lorefice L, Pitzalis M, Murgia F, Fenu G, Atzori L, Cocco E (2023) Omics approaches to understanding the efficacy and safety of disease-modifying treatments in multiple sclerosis. Front Genet 14:1076421","journal-title":"Front Genet"},{"key":"1596_CR49","doi-asserted-by":"publisher","first-page":"246","DOI":"10.3389\/fimmu.2016.00246","volume":"7","author":"MD Lovelace","year":"2016","unstructured":"Lovelace MD, Varney B, Sundaram G, Franco NF, Ng ML, Pai S, Lim CK, Guillemin GJ, Brew BJ (2016) Current evidence for a role of the kynurenine pathway of tryptophan metabolism in multiple sclerosis. Front Immunol 7:246","journal-title":"Front Immunol"},{"key":"1596_CR50","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.neuropharm.2016.03.024","volume":"112","author":"MD Lovelace","year":"2017","unstructured":"Lovelace MD, Varney B, Sundaram G, Lennon MJ, Lim CK, Jacobs K, Guillemin GJ, Brew BJ (2017) Recent evidence for an expanded role of the kynurenine pathway of tryptophan metabolism in neurological diseases. Neuropharmacology 112:373\u2013388","journal-title":"Neuropharmacology"},{"issue":"6","key":"1596_CR51","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0130715","volume":"10","author":"R Mancuso","year":"2015","unstructured":"Mancuso R, Hernis A, Agostini S, Rovaris M, Caputo D, Fuchs D, Clerici M (2015) Indoleamine 2, 3 dioxygenase (IDO) expression and activity in relapsing-remitting multiple sclerosis. PLoS ONE 10(6):e0130715","journal-title":"PLoS ONE"},{"key":"1596_CR52","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/s00702-011-0681-y","volume":"119","author":"Y M\u00e1ndi","year":"2012","unstructured":"M\u00e1ndi Y, V\u00e9csei L (2012) The kynurenine system and immunoregulation. J Neural Transm 119:197\u2013209","journal-title":"J Neural Transm"},{"issue":"2","key":"1596_CR53","doi-asserted-by":"publisher","first-page":"13","DOI":"10.3390\/physiologia5020013","volume":"5","author":"M Mansoor","year":"2025","unstructured":"Mansoor M, Ibrahim A, Hamide A, Tran T, Candreva E, Baltaji J (2025) Exercise-induced neuroplasticity: adaptive mechanisms and preventive potential in neurodegenerative disorders. Physiologia 5(2):13","journal-title":"Physiologia"},{"issue":"12","key":"1596_CR54","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.3390\/biology10121325","volume":"10","author":"R De Masi","year":"2021","unstructured":"De Masi R, Orlando S, Bagordo F, Grassi T (2021) IFP35 is a relevant factor in innate immunity, multiple sclerosis, and other chronic inflammatory diseases: a review. Biology 10(12):1325","journal-title":"Biology"},{"issue":"11","key":"1596_CR55","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1139\/apnm-2014-0092","volume":"39","author":"MO Melancon","year":"2014","unstructured":"Melancon MO, Lorrain D, Dionne IJ (2014) Changes in markers of brain serotonin activity in response to chronic exercise in senior men. Appl Physiol Nutr Metab 39(11):1250\u20131256","journal-title":"Appl Physiol Nutr Metab"},{"issue":"10","key":"1596_CR56","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.3390\/biom14101241","volume":"14","author":"AK Mitchell","year":"2024","unstructured":"Mitchell AK, Bliss RR, Church FC (2024) Exercise, neuroprotective exerkines, and Parkinson\u2019s disease: a narrative review. Biomolecules 14(10):1241","journal-title":"Biomolecules"},{"issue":"7","key":"1596_CR57","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.3390\/cells10071603","volume":"10","author":"A Mor","year":"2021","unstructured":"Mor A, Tankiewicz-Kwedlo A, Krupa A, Pawlak D (2021) Role of kynurenine pathway in oxidative stress during neurodegenerative disorders. Cells 10(7):1603","journal-title":"Cells"},{"issue":"4","key":"1596_CR58","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1249\/JES.0000000000000325","volume":"51","author":"KM Naugle","year":"2023","unstructured":"Naugle KM, Naugle KE, Teegardin M, Kaleth AS (2023) Physical activity to prevent the age-related decline of endogenous pain modulation. Exerc Sport Sci Rev 51(4):169\u2013175","journal-title":"Exerc Sport Sci Rev"},{"issue":"8","key":"1596_CR59","doi-asserted-by":"publisher","first-page":"4052","DOI":"10.3390\/ijms22084052","volume":"22","author":"K Nay","year":"2021","unstructured":"Nay K, Smiles WJ, Kaiser J, McAloon LM, Loh K, Galic S, Oakhill JS, Gundlach AL, Scott JW (2021) Molecular mechanisms underlying the beneficial effects of exercise on brain function and neurological disorders. Int J Mol Sci 22(8):4052","journal-title":"Int J Mol Sci"},{"issue":"13","key":"1596_CR60","doi-asserted-by":"publisher","first-page":"4200","DOI":"10.1523\/JNEUROSCI.5032-08.2009","volume":"29","author":"JC O'Connor","year":"2009","unstructured":"O\u2019Connor JC, Andr\u00e9 C, Wang Y, Lawson MA, Szegedi SS, Lestage J, Castanon N, Kelley KW, Dantzer R (2009) Interferon-\u03b3 and tumor necrosis factor-\u03b1 mediate the upregulation of indoleamine 2, 3-dioxygenase and the induction of depressive-like behavior in mice in response to bacillus Calmette-Guerin. J Neurosci 29(13):4200\u20134209","journal-title":"J Neurosci"},{"key":"1596_CR61","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.661493","volume":"12","author":"A Olsson","year":"2021","unstructured":"Olsson A, Gustavsen S, Nguyen TD, Nyman M, Langkilde AR, Hansen TH, Sellebjerg F, Oturai AB, Bach S\u00f8ndergaard H (2021) Serum short-chain fatty acids and associations with inflammation in newly diagnosed patients with multiple sclerosis and healthy controls. Front Immunol 12:661493","journal-title":"Front Immunol"},{"issue":"1","key":"1596_CR62","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/cns.13768","volume":"28","author":"A Ostapiuk","year":"2022","unstructured":"Ostapiuk A, Urbanska EM (2022) Kynurenic acid in neurodegenerative disorders\u2014unique neuroprotection or double-edged sword? CNS Neurosci Ther 28(1):19\u201335","journal-title":"CNS Neurosci Ther"},{"issue":"20","key":"1596_CR63","doi-asserted-by":"publisher","first-page":"6099","DOI":"10.1111\/febs.16086","volume":"289","author":"MT Pallotta","year":"2022","unstructured":"Pallotta MT, Rossini S, Suvieri C, Coletti A, Orabona C, Macchiarulo A, Volpi C, Grohmann U (2022) Indoleamine 2, 3-dioxygenase 1 (IDO1): an up-to-date overview of an eclectic immunoregulatory enzyme. FEBS J 289(20):6099\u20136118","journal-title":"FEBS J"},{"issue":"2","key":"1596_CR64","doi-asserted-by":"publisher","first-page":"853","DOI":"10.3390\/ijms25020853","volume":"25","author":"S Pathak","year":"2024","unstructured":"Pathak S, Nadar R, Kim S, Liu K, Govindarajulu M, Cook P, Watts Alexander CS, Dhanasekaran M, Moore T (2024) The influence of kynurenine metabolites on neurodegenerative pathologies. Int J Mol Sci 25(2):853","journal-title":"Int J Mol Sci"},{"issue":"1","key":"1596_CR65","doi-asserted-by":"publisher","DOI":"10.1136\/bmjsem-2024-002432","volume":"11","author":"GA Paz","year":"2025","unstructured":"Paz GA, Rangel MV, Farias CL, Soares ALC, Langner E, Teixeira T, Dutra PM, Bouskela E, Farinatti P, Souza MdGC (2025) Acute and chronic effects of physical exercise on atherosclerosis, kynurenine pathway, endothelial function and inflammation in patients with coronary artery disease: a clinical trial protocol. BMJ Open Sport Exerc Med 11(1):e002432","journal-title":"BMJ Open Sport Exerc Med"},{"key":"1596_CR66","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/sms.12581","volume":"25","author":"BK Pedersen","year":"2015","unstructured":"Pedersen BK, Saltin B (2015) Exercise as medicine\u2013evidence for prescribing exercise as therapy in 26 different chronic diseases. Scand J Med Sci Sports 25:1\u201372","journal-title":"Scand J Med Sci Sports"},{"issue":"1","key":"1596_CR67","volume":"2020","author":"V Pegoretti","year":"2020","unstructured":"Pegoretti V, Swanson KA, Bethea JR, Probert L, Eisel UL, Fischer R (2020) Inflammation and oxidative stress in multiple sclerosis: consequences for therapy development. Oxid Med Cell Longev 2020(1):7191080","journal-title":"Oxid Med Cell Longev"},{"key":"1596_CR68","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2014.00170","volume":"8","author":"C Phillips","year":"2014","unstructured":"Phillips C, Baktir MA, Srivatsan M, Salehi A (2014) Neuroprotective effects of physical activity on the brain: a closer look at trophic factor signaling. Front Cell Neurosci 8:170","journal-title":"Front Cell Neurosci"},{"issue":"5","key":"1596_CR69","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1080\/10715760100300391","volume":"34","author":"J Pl\u00e1ten\u00edk","year":"2001","unstructured":"Pl\u00e1ten\u00edk J, Stopka P, Vejra\u017eka M, \u0160t\u00edpek S (2001) Quinolinic acid\u2014Iron (II) complexes: slow autoxidation, but enhanced hydroxyl radical production in the Fenton reaction. Free Radic Res 34(5):445\u2013459","journal-title":"Free Radic Res"},{"key":"1596_CR70","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2021.e06124","author":"H Poly\u00e1k","year":"2021","unstructured":"Poly\u00e1k H, Cseh EK, Boh\u00e1r Z, Rajda C, Z\u00e1dori D, Kliv\u00e9nyi P, Toldi J, V\u00e9csei L (2021) Cuprizone markedly decreases kynurenic acid levels in the rodent brain tissue and plasma. Heliyon. https:\/\/doi.org\/10.1016\/j.heliyon.2021.e06124","journal-title":"Heliyon"},{"issue":"3","key":"1596_CR71","doi-asserted-by":"publisher","first-page":"976","DOI":"10.3390\/ijms26030976","volume":"26","author":"H Poly\u00e1k","year":"2025","unstructured":"Poly\u00e1k H, Galla Z, Rajda C, Monostori P, Kliv\u00e9nyi P, V\u00e9csei L (2025) Plasma and visceral organ kynurenine metabolites correlate in the multiple sclerosis cuprizone animal model. Int J Mol Sci 26(3):976","journal-title":"Int J Mol Sci"},{"key":"1596_CR72","doi-asserted-by":"publisher","first-page":"100977","DOI":"10.1016\/j.lanepe.2024.100977","volume":"44","author":"E Portaccio","year":"2024","unstructured":"Portaccio E, Magyari M, Havrdova EK, Ruet A, Brochet B, Scalfari A, Di Filippo M, Tur C, Montalban X, Amato MP (2024) Multiple sclerosis: emerging epidemiological trends and redefining the clinical course. Lancet Reg Health-Europe 44:100977","journal-title":"Lancet Reg Health-Europe"},{"issue":"11","key":"1596_CR73","doi-asserted-by":"publisher","first-page":"5098","DOI":"10.3390\/ijms26115098","volume":"26","author":"D Pukoli","year":"2025","unstructured":"Pukoli D, V\u00e9csei L (2025) Kynurenines and mitochondrial disturbances in multiple sclerosis. Int J Mol Sci 26(11):5098","journal-title":"Int J Mol Sci"},{"key":"1596_CR74","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2021.658202","volume":"15","author":"D Pukoli","year":"2021","unstructured":"Pukoli D, Poly\u00e1k H, Rajda C, V\u00e9csei L (2021) Kynurenines and neurofilament light chain in multiple sclerosis. Front Neurosci 15:658202","journal-title":"Front Neurosci"},{"issue":"15","key":"1596_CR75","doi-asserted-by":"publisher","first-page":"4195","DOI":"10.1111\/jcmm.17404","volume":"26","author":"S Raimondo","year":"2022","unstructured":"Raimondo S, Urz\u00ec O, Meraviglia S, Di Simone M, Corsale AM, Rabienezhad Ganji N, Palumbo Piccionello A, Polito G, Lo Presti E, Dieli F (2022) Anti-inflammatory properties of lemon-derived extracellular vesicles are achieved through the inhibition of ERK\/NF-\u03baB signalling pathways. J Cell Mol Med 26(15):4195\u20134209","journal-title":"J Cell Mol Med"},{"issue":"8","key":"1596_CR76","doi-asserted-by":"publisher","first-page":"18270","DOI":"10.3390\/ijms160818270","volume":"16","author":"C Rajda","year":"2015","unstructured":"Rajda C, Majl\u00e1th Z, Pukoli D, V\u00e9csei L (2015) Kynurenines and multiple sclerosis: the dialogue between the immune system and the central nervous system. Int J Mol Sci 16(8):18270\u201318282","journal-title":"Int J Mol Sci"},{"issue":"8","key":"1596_CR77","doi-asserted-by":"publisher","first-page":"2665","DOI":"10.3390\/ijms21082665","volume":"21","author":"C Rajda","year":"2020","unstructured":"Rajda C, Galla Z, Poly\u00e1k H, Mar\u00f3ti Z, Babarczy K, Pukoli D, V\u00e9csei L (2020) Cerebrospinal fluid neurofilament light chain is associated with kynurenine pathway metabolite changes in multiple sclerosis. Int J Mol Sci 21(8):2665","journal-title":"Int J Mol Sci"},{"issue":"1","key":"1596_CR78","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/S0304-3940(02)00710-3","volume":"331","author":"K Rejdak","year":"2002","unstructured":"Rejdak K, Bartosik-Psujek H, Dobosz B, Kocki T, Grieb P, Giovannoni G, Turski WA, Stelmasiak Z (2002) Decreased level of kynurenic acid in cerebrospinal fluid of relapsing-onset multiple sclerosis patients. Neurosci Lett 331(1):63\u201365","journal-title":"Neurosci Lett"},{"key":"1596_CR79","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1007\/s00702-007-0667-y","volume":"114","author":"K Rejdak","year":"2007","unstructured":"Rejdak K, Petzold A, Kocki T, Kurzepa J, Grieb P, Turski W, Stelmasiak Z (2007) Astrocytic activation in relation to inflammatory markers during clinical exacerbation of relapsing-remitting multiple sclerosis. J Neural Transm 114:1011\u20131015","journal-title":"J Neural Transm"},{"issue":"16","key":"1596_CR80","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1089\/ars.2021.0215","volume":"37","author":"R Ren","year":"2022","unstructured":"Ren R, Fang Y, Sherchan P, Lu Q, Lenahan C, Zhang JH, Zhang J, Tang J (2022) Kynurenine\/aryl hydrocarbon receptor modulates mitochondria-mediated oxidative stress and neuronal apoptosis in experimental intracerebral hemorrhage. Antioxid Redox Signal 37(16):1111\u20131129","journal-title":"Antioxid Redox Signal"},{"issue":"1","key":"1596_CR81","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1089\/jir.2005.25.20","volume":"25","author":"CM Robinson","year":"2005","unstructured":"Robinson CM, Hale PT, Carlin JM (2005) The role of IFN-\u03b3 and TNF-\u03b1-responsive regulatory elements in the synergistic induction of indoleamine dioxygenase. J Interferon Cytokine Res 25(1):20\u201330","journal-title":"J Interferon Cytokine Res"},{"key":"1596_CR82","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3389\/fmolb.2019.00007","volume":"6","author":"F Rossi","year":"2019","unstructured":"Rossi F, Miggiano R, Ferraris DM, Rizzi M (2019) The synthesis of kynurenic acid in mammals: an updated kynurenine aminotransferase structural KATalogue. Front Mol Biosci 6:7","journal-title":"Front Mol Biosci"},{"issue":"2","key":"1596_CR83","first-page":"274","volume":"24","author":"M Rostaminejad","year":"2019","unstructured":"Rostaminejad M, Rostaminejad A, Kalantari T (2019) Materials and metabolites of kynureinine pathway in neurodegenerative diseases and multiple sclerosis. Armaghane Danesh 24(2):274\u2013292","journal-title":"Armaghane Danesh"},{"issue":"7","key":"1596_CR84","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.3390\/antiox11071223","volume":"11","author":"L S\u00e1nchez Chapul","year":"2022","unstructured":"S\u00e1nchez Chapul L, P\u00e9rez de la Cruz G, Ramos Ch\u00e1vez LA, Valencia Le\u00f3n JF, Torres Beltr\u00e1n J, Estrada Camarena E, Carillo Mora P, Ram\u00edrez Ortega D, Ba\u00f1os V\u00e1zquez JU, Mart\u00ednez Nava G (2022) Characterization of redox environment and tryptophan catabolism through kynurenine pathway in military divers\u2019 and swimmers\u2019 serum samples. Antioxidants 11(7):1223","journal-title":"Antioxidants"},{"key":"1596_CR85","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2022.103667","volume":"59","author":"M Saraste","year":"2022","unstructured":"Saraste M, Matilainen M, Rajda C, Galla Z, Sucksdorff M, V\u00e9csei L, Airas L (2022) Association between microglial activation and serum kynurenine pathway metabolites in multiple sclerosis patients. Mult Scler Relat Disord 59:103667","journal-title":"Mult Scler Relat Disord"},{"key":"1596_CR86","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1007\/s00421-020-04552-w","volume":"121","author":"A Schenk","year":"2021","unstructured":"Schenk A, Joisten N, Walzik D, Koliamitra C, Schoser D, Bloch W, Zimmer P (2021) Acute exercise impacts AhR and PD-1 levels of CD8+ T-cells\u2014exploratory results from a randomized cross-over trial comparing endurance versus resistance exercise. Eur J Appl Physiol 121:637\u2013644","journal-title":"Eur J Appl Physiol"},{"issue":"10","key":"1596_CR87","doi-asserted-by":"publisher","first-page":"C836","DOI":"10.1152\/ajpcell.00053.2016","volume":"310","author":"M Schlittler","year":"2016","unstructured":"Schlittler M, Goiny M, Agudelo LZ, Venckunas T, Brazaitis M, Skurvydas A, Kamandulis S, Ruas JL, Erhardt S, Westerblad H (2016) Endurance exercise increases skeletal muscle kynurenine aminotransferases and plasma kynurenic acid in humans. Am J Physiol Cell Physiol 310(10):C836\u2013C840","journal-title":"Am J Physiol Cell Physiol"},{"key":"1596_CR88","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2023.115258","volume":"251","author":"H Shen","year":"2023","unstructured":"Shen H, Xu X, Bai Y, Wang X, Wu Y, Zhong J, Wu Q, Luo Y, Shang T, Shen R (2023) Therapeutic potential of targeting kynurenine pathway in neurodegenerative diseases. Eur J Med Chem 251:115258","journal-title":"Eur J Med Chem"},{"key":"1596_CR89","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2015.00069","volume":"6","author":"DM Shore","year":"2015","unstructured":"Shore DM, Reggio PH (2015) The therapeutic potential of orphan GPCRs, GPR35 and GPR55. Front Pharmacol 6:69","journal-title":"Front Pharmacol"},{"key":"1596_CR90","doi-asserted-by":"publisher","DOI":"10.1249\/mss.0000000000003488","author":"K Sigitas","year":"2024","unstructured":"Sigitas K, Inga L, Audrius S, Marius B, Mantas M, Margarita C, Jorge R, Lilly S, Varvara L, Sophie E (2024) Mood, cognitive function, and plasma kynurenine metabolites responses following severe changes in physical activity. Med Sci Sports Exercise. https:\/\/doi.org\/10.1249\/mss.0000000000003488","journal-title":"Med Sci Sports Exercise"},{"key":"1596_CR91","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.bbi.2021.07.010","volume":"97","author":"RJ Simpson","year":"2021","unstructured":"Simpson RJ, Bo\u00dflau TK, Weyh C, Niemiro GM, Batatinha H, Smith KA, Kr\u00fcger K (2021) Exercise and adrenergic regulation of immunity. Brain Behav Immun 97:303\u2013318","journal-title":"Brain Behav Immun"},{"issue":"6","key":"1596_CR92","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1002\/eji.202048580","volume":"51","author":"SP Sittig","year":"2021","unstructured":"Sittig SP, van Beek JJ, Fl\u00f3rez-Grau G, Weiden J, Buschow SI, van der Net MC, van Slooten R, Verbeek MM, Geurtz PBH, Textor J (2021) Human type 1 and type 2 conventional dendritic cells express indoleamine 2, 3-dioxygenase 1 with functional effects on T cell priming. Eur J Immunol 51(6):1494\u20131504","journal-title":"Eur J Immunol"},{"issue":"2","key":"1596_CR93","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000200372","volume":"12","author":"A Staats Pires","year":"2025","unstructured":"Staats Pires A, Krishnamurthy S, Sharma S, Chow S, Klistorner S, Guillemin GJ, Klistorner A, You Y, Heng B (2025) Dysregulation of the kynurenine pathway in relapsing remitting multiple sclerosis and its correlations with progressive neurodegeneration. Neurol Neuroimmunol Neuroinflamm 12(2):e200372","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"1","key":"1596_CR94","doi-asserted-by":"publisher","first-page":"39","DOI":"10.2174\/2772432817666220412110720","volume":"18","author":"V-P Stamatellos","year":"2023","unstructured":"Stamatellos V-P, Papazisis G (2023) Safety and monitoring of the treatment with disease-modifying therapies (DMTs) for multiple sclerosis (MS). Curr Rev Clin Exp Pharmacol Former Curr Clin Pharmacol 18(1):39\u201350","journal-title":"Curr Rev Clin Exp Pharmacol Former Curr Clin Pharmacol"},{"issue":"6","key":"1596_CR95","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1111\/bph.12230","volume":"169","author":"TW Stone","year":"2013","unstructured":"Stone TW, Darlington LG (2013) The kynurenine pathway as a therapeutic target in cognitive and neurodegenerative disorders. Br J Pharmacol 169(6):1211\u20131227","journal-title":"Br J Pharmacol"},{"issue":"4","key":"1596_CR96","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0153617","volume":"11","author":"B Strasser","year":"2016","unstructured":"Strasser B, Geiger D, Schauer M, Gatterer H, Burtscher M, Fuchs D (2016) Effects of exhaustive aerobic exercise on tryptophan-kynurenine metabolism in trained athletes. PLoS ONE 11(4):e0153617","journal-title":"PLoS ONE"},{"key":"1596_CR97","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12974-020-01844-y","volume":"17","author":"G Sundaram","year":"2020","unstructured":"Sundaram G, Lim CK, Brew BJ, Guillemin GJ (2020) Kynurenine pathway modulation reverses the experimental autoimmune encephalomyelitis mouse disease progression. J Neuroinflammation 17:1\u201314","journal-title":"J Neuroinflammation"},{"issue":"5\u20136","key":"1596_CR98","first-page":"212","volume":"20","author":"F Tadayon Zadeh","year":"2021","unstructured":"Tadayon Zadeh F, Amini H, Habibi S, Shahedi V, Isanejad A, Akbarpour M (2021) The effects of 8-week combined exercise training on inflammatory markers in women with multiple sclerosis. Neurodegener Dis 20(5\u20136):212\u2013216","journal-title":"Neurodegener Dis"},{"issue":"24","key":"1596_CR99","doi-asserted-by":"publisher","first-page":"9338","DOI":"10.3390\/ijms21249338","volume":"21","author":"N T\u00f6r\u00f6k","year":"2020","unstructured":"T\u00f6r\u00f6k N, Tanaka M, V\u00e9csei L (2020) Searching for peripheral biomarkers in neurodegenerative diseases: the tryptophan-kynurenine metabolic pathway. Int J Mol Sci 21(24):9338","journal-title":"Int J Mol Sci"},{"key":"1596_CR100","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2021.761674","volume":"13","author":"H Umegaki","year":"2021","unstructured":"Umegaki H, Sakurai T, Arai H (2021) Active life for brain health: a narrative review of the mechanism underlying the protective effects of physical activity on the brain. Front Aging Neurosci 13:761674","journal-title":"Front Aging Neurosci"},{"issue":"8","key":"1596_CR101","doi-asserted-by":"publisher","DOI":"10.3390\/metabo11080508","volume":"11","author":"P Valente-Silva","year":"2021","unstructured":"Valente-Silva P, Cervenka I, Ferreira DM, Correia JC, Edman S, Horwath O, Heng B, Chow S, Jacobs KR, Guillemin GJ (2021) Effects of tryptophan supplementation and exercise on the fate of kynurenine metabolites in mice and humans. Metabolites 11(8):508","journal-title":"Metabolites"},{"issue":"5","key":"1596_CR102","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1136\/jim-2016-000339","volume":"65","author":"DL Vargas","year":"2017","unstructured":"Vargas DL, Tyor WR (2017) Update on disease-modifying therapies for multiple sclerosis. J Invest Med 65(5):883\u2013891","journal-title":"J Invest Med"},{"issue":"1","key":"1596_CR103","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1038\/nrd3793","volume":"12","author":"L V\u00e9csei","year":"2013","unstructured":"V\u00e9csei L, Szal\u00e1rdy L, F\u00fcl\u00f6p F, Toldi J (2013) Kynurenines in the CNS: recent advances and new questions. Nat Rev Drug Discov 12(1):64\u201382","journal-title":"Nat Rev Drug Discov"},{"issue":"3\u20134","key":"1596_CR104","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1515\/teb-2024-0037","volume":"1","author":"TY Wences Chirino","year":"2024","unstructured":"Wences Chirino TY, Joisten N, Zimmer P, Proschinger S (2024) How exercise shapes the anti-inflammatory environment in multiple sclerosis\u2013a conceptual framework focusing on tryptophan-derived molecules in T cell differentiation. Translat Exer Biomed 1(3\u20134):305\u2013319","journal-title":"Translat Exer Biomed"},{"key":"1596_CR105","doi-asserted-by":"publisher","first-page":"1367734","DOI":"10.3389\/fimmu.2024.1367734","volume":"15","author":"L Xu","year":"2024","unstructured":"Xu L, Lin L, Xie N, Chen W, Nong W, Li R (2024) Role of aryl hydrocarbon receptors in infection and inflammation. Front Immunol 15:1367734","journal-title":"Front Immunol"},{"key":"1596_CR106","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2023.115717","volume":"215","author":"Y-N Yang","year":"2023","unstructured":"Yang Y-N, Zhang M-Q, Yu F-L, Han B, Bao M-Y, Li X, Zhang Y (2023) Peroxisom proliferator-activated receptor-\u03b3 coactivator-1\u03b1 in neurodegenerative disorders: a promising therapeutic target. Biochem Pharmacol 215:115717","journal-title":"Biochem Pharmacol"},{"issue":"20","key":"1596_CR107","doi-asserted-by":"publisher","first-page":"3709","DOI":"10.3390\/molecules24203709","volume":"24","author":"F Z\u00e1dor","year":"2019","unstructured":"Z\u00e1dor F, Nagy-Gr\u00f3cz G, Kekesi G, Dvor\u00e1csk\u00f3 S, Sz\u0171cs E, T\u00f6mb\u00f6ly C, Horvath G, Benyhe S, V\u00e9csei L (2019) Kynurenines and the endocannabinoid system in schizophrenia: common points and potential interactions. Molecules 24(20):3709","journal-title":"Molecules"},{"issue":"06","key":"1596_CR108","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1055\/s-0040-1722186","volume":"121","author":"Y Zhao","year":"2021","unstructured":"Zhao Y, Xu P, Guo L, Wang H, Min Y, Feng Q, Hou Y, Sun T, Li G, Ji X (2021) Tumor necrosis factor-\u03b1 blockade corrects monocyte\/macrophage imbalance in primary immune thrombocytopenia. Thromb Haemost 121(06):767\u2013781","journal-title":"Thromb Haemost"},{"key":"1596_CR109","unstructured":"Proschinger S, Winker M, Joisten N, Bloch W, Palmowski J, Zimmer P: The effect of exercise on regulatory T cells: A systematic review of human and animal studies with future perspectives and methodological recommendations. Exercise immunology review 2021, 27."}],"container-title":["Cellular and Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10571-025-01596-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10571-025-01596-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10571-025-01596-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T11:03:44Z","timestamp":1765537424000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10571-025-01596-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,22]]},"references-count":109,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1596"],"URL":"https:\/\/doi.org\/10.1007\/s10571-025-01596-4","relation":{},"ISSN":["1573-6830"],"issn-type":[{"value":"1573-6830","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,22]]},"assertion":[{"value":"23 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that this research was conducted without any commercial or financial associations that could be considered a potential conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"All authors actively contributed to the manuscript\u2019s development, reviewed the final version, and gave their approval for publication.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}}],"article-number":"74"}}